Andexxa coagulation factor Xa recombinantinactivated-zhzo is a recombinant modified human Factor Xa FXa protein indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. Andexxa coagulation factor Xa recombinantinactivated-zhzo Consumer Information.

Always consult your healthcare provider to ensure the information Roanoke Fence Company on this page applies to your personal circumstances. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

Subscribe to Drugs. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.

We comply with the HONcode standard for trustworthy health information - verify here. Skip to Content. Treatment for: Reversal of Anticoagulant Activity of Factor Xa Inhibitors Andexxx coagulation factor Xa recombinant Andexxa Company, inactivated-zhzo is a recombinant modified human Factor Xa FXa protein indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

Drug Status Rx. Availability Prescription only. Subscribe to our newsletters. FDA alerts for all Adexxa. Daily news summary. Weekly news roundup. Monthly newsletter. I accept the Terms and Privacy Policy. Email Address. Recently Approved. Sarclisa Sarclisa isatuximab-irfc is a CDdirected cytolytic antibody indicated in Nexlizet Nexlizet bempedoic acid and ezetimibe is an adenosine triphosphate-citrate Explore Apps.

About About Drugs. All rights reserved. Food and Drug Andexxa Company for Andexanet Alfa.

Andexxa – Andexxa

ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.…

About Andexxa

ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.…

Portola Announces Preliminary Full Year 2019 Andexxa ...

Jan 09, 2020 · The Company's first two commercialized products are Andexxa ®  [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya ®  (andexanet alfa), and Bevyxxa ®  (betrixaban). The company also is advancing cerdulatinib, a SYK/JAK inhibitor being developed for the treatment of hematologic cancers.…